![Tina Albertson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tina Albertson
Technik-/Wissenschafts-/F&E-Leiter bei
CARIBOU BIOSCIENCES, INC.
Vermögen: 161 714 $ am 31.05.2026
Profil
Tina Albertson is currently Chief Medical Officer at Caribou Biosciences, Inc. since 2024.
Formerly, Dr. Albertson was Chief Medical Officer & Head-Development at Lyell Immunopharma, Inc. from 2020 to 2023, Vice President-Global Drug Development at Juno Therapeutics, Inc. from 2015 to 2020, and Medical Director at Seagen, Inc. from 2010 to 2015.
Education includes a doctorate from Stanford University, a doctorate from the University of Washington, and an undergraduate degree from the University of Oregon.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 24.02.2026 | 68.523 ( 0,07 % ) | 161 714 $ | 31.05.2026 |
Aktive Positionen von Tina Albertson
| Unternehmen | Position | Beginn |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 12.08.2024 |
Ehemalige bekannte Positionen von Tina Albertson
| Unternehmen | Position | Ende |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2023 |
| JUNO THERAPEUTICS INC | Corporate Officer/Principal | 01.04.2020 |
| SEAGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2015 |
Ausbildung von Tina Albertson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
46
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Caribou Biosciences, Inc.
 Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oregon
 University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Lyell Immunopharma, Inc.
 Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
Wählen Sie MarketScreener 
